Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Shares Issued (2016 - 2025)

Traws Pharma (TRAW) has disclosed Shares Issued for 14 consecutive years, with $116000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued changed N/A to $116000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $9.5 million, a 531.53% increase, with the full-year FY2024 number at $20.0 million, changed N/A from a year prior.
  • Shares Issued was $116000.0 for Q3 2025 at Traws Pharma, down from $3.3 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $35.1 million in Q2 2021 to a low of -$55.1 million in Q4 2021.
  • A 5-year average of -$496214.3 and a median of $500000.0 in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: crashed 4569.72% in 2021, then surged 2841.18% in 2022.
  • Traws Pharma's Shares Issued stood at -$55.1 million in 2021, then skyrocketed by 100.91% to $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then soared by 1095.6% to $6.0 million in 2024, then crashed by 98.06% to $116000.0 in 2025.
  • Per Business Quant, the three most recent readings for TRAW's Shares Issued are $116000.0 (Q3 2025), $3.3 million (Q2 2025), and $122000.0 (Q1 2025).